94 related articles for article (PubMed ID: 19610065)
1. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
2. Stromal anti-apoptotic androgen receptor target gene c-FLIP in prostate cancer.
Ye H; Li Y; Melamed J; Pearce P; Wei J; Chiriboga L; Wang Z; Osman I; Lee P
J Urol; 2009 Feb; 181(2):872-7. PubMed ID: 19095249
[TBL] [Abstract][Full Text] [Related]
3. LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion.
Li Y; Wang L; Zhang M; Melamed J; Liu X; Reiter R; Wei J; Peng Y; Zou X; Pellicer A; Garabedian MJ; Ferrari A; Lee P
Cancer Res; 2009 Apr; 69(8):3332-8. PubMed ID: 19351848
[TBL] [Abstract][Full Text] [Related]
4. Loss of mir-146a function in hormone-refractory prostate cancer.
Lin SL; Chiang A; Chang D; Ying SY
RNA; 2008 Mar; 14(3):417-24. PubMed ID: 18174313
[TBL] [Abstract][Full Text] [Related]
5. Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer.
Mandigo AC; Shafi AA; McCann JJ; Yuan W; Laufer TS; Bogdan D; Gallagher L; Dylgjeri E; Semenova G; Vasilevskaya IA; Schiewer MJ; McNair CM; de Bono JS; Knudsen KE
Cancer Res; 2022 Jan; 82(2):221-234. PubMed ID: 34625422
[TBL] [Abstract][Full Text] [Related]
6. Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.
Mad'arová J; Lukesová M; Hlobilková A; Strnad M; Vojtesek B; Lenobel R; Hajdúch M; Murray PG; Perera S; Kolár Z
Mol Pathol; 2002 Aug; 55(4):227-34. PubMed ID: 12147712
[TBL] [Abstract][Full Text] [Related]
7. ID4 promotes AR expression and blocks tumorigenicity of PC3 prostate cancer cells.
Komaragiri SK; Bostanthirige DH; Morton DJ; Patel D; Joshi J; Upadhyay S; Chaudhary J
Biochem Biophys Res Commun; 2016 Sep; 478(1):60-66. PubMed ID: 27462022
[TBL] [Abstract][Full Text] [Related]
8. Proteomic comparison of prostate cancer cell lines LNCaP-FGC and LNCaP-r reveals heatshock protein 60 as a marker for prostate malignancy.
Johansson B; Pourian MR; Chuan YC; Byman I; Bergh A; Pang ST; Norstedt G; Bergman T; Pousette A
Prostate; 2006 Sep; 66(12):1235-44. PubMed ID: 16705742
[TBL] [Abstract][Full Text] [Related]
9. Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.
Marques RB; Dits NF; Erkens-Schulze S; van Weerden WM; Jenster G
PLoS One; 2010 Oct; 5(10):e13500. PubMed ID: 20976069
[TBL] [Abstract][Full Text] [Related]
10. Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells.
Koushyar S; Uysal-Onganer P; Jiang WG; Dart DA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373067
[TBL] [Abstract][Full Text] [Related]
11. ANX7, a candidate tumor suppressor gene for prostate cancer.
Srivastava M; Bubendorf L; Srikantan V; Fossom L; Nolan L; Glasman M; Leighton X; Fehrle W; Pittaluga S; Raffeld M; Koivisto P; Willi N; Gasser TC; Kononen J; Sauter G; Kallioniemi OP; Srivastava S; Pollard HB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4575-80. PubMed ID: 11287641
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer.
Martin-Caraballo M
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673756
[TBL] [Abstract][Full Text] [Related]
13. Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer Cells.
Thakur G; Prakash G; Murthy V; Sable N; Menon S; Alrokayan SH; Khan HA; Murugaiah V; Bakshi G; Kishore U; Madan T
Front Oncol; 2019; 9():565. PubMed ID: 31355132
[TBL] [Abstract][Full Text] [Related]
14. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.
Kumar A; Coleman I; Morrissey C; Zhang X; True LD; Gulati R; Etzioni R; Bolouri H; Montgomery B; White T; Lucas JM; Brown LG; Dumpit RF; DeSarkar N; Higano C; Yu EY; Coleman R; Schultz N; Fang M; Lange PH; Shendure J; Vessella RL; Nelson PS
Nat Med; 2016 Apr; 22(4):369-78. PubMed ID: 26928463
[TBL] [Abstract][Full Text] [Related]
15. Annexin A7 and Its Related Protein Suppressor of Death Domains Regulates Migration and Proliferation of Hca-P Cells.
Wang S; Bai Q; Yu X; Gao F; Sun Y; Wang X
Cell J; 2023 Nov; 25(11):801-808. PubMed ID: 38071412
[TBL] [Abstract][Full Text] [Related]
16. Rbf/E2F1 control growth and endoreplication via steroid-independent Ecdysone Receptor signalling in Drosophila prostate-like secondary cells.
Sekar A; Leiblich A; Wainwright SM; Mendes CC; Sarma D; Hellberg JEEU; Gandy C; Goberdhan DCI; Hamdy FC; Wilson C
PLoS Genet; 2023 Jun; 19(6):e1010815. PubMed ID: 37363926
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of annexin A7 suppresses senescence-associated heterochromatin foci formation and senescence through the AMPK/mTOR pathway in human dermal fibroblasts.
Li N; Yan X; Cui X; Zhao C; Lin Z; Miao J
J Cell Biochem; 2023 Oct; 124(10):1603-1614. PubMed ID: 37682859
[TBL] [Abstract][Full Text] [Related]
18. Modeling a lethal prostate cancer variant with small-cell carcinoma features.
Tzelepi V; Zhang J; Lu JF; Kleb B; Wu G; Wan X; Hoang A; Efstathiou E; Sircar K; Navone NM; Troncoso P; Liang S; Logothetis CJ; Maity SN; Aparicio AM
Clin Cancer Res; 2012 Feb; 18(3):666-77. PubMed ID: 22156612
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells.
Hastie C; Masters JR; Moss SE; Naaby-Hansen S
J Biol Chem; 2008 May; 283(18):12595-603. PubMed ID: 18211896
[TBL] [Abstract][Full Text] [Related]
20. Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance.
Inder S; Bates M; Ni Labhrai N; McDermott N; Schneider J; Erdmann G; Jamerson T; Belle VA; Prina-Mello A; Thirion P; Manecksha PR; Cormican D; Finn S; Lynch T; Marignol L
Sci Rep; 2019 Nov; 9(1):17325. PubMed ID: 31758038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]